Clinical Trial Update: A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

View source ↗

Summary

A US-based prospective study examining mogamulizumab-associated rash in patients with mycosis fungoides or Sézary syndrome who are treated with standard-of-care…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Poteligeo (mogamulizumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Mycosis Fungoides, Recurrent Sezary Syndrome | Status: RECRUITING